Development of anti-OKT3 antibodies after OKT3 treatment

Scandinavian Journal of Urology and Nephrology

Volumn 30, Issue 3, 1996, Pages 227-230

  Jensen, Per B ^a   Birkeland, Sven A ^a   Rohr, Niels ^a   Elbirk, Anders ^a   Jørgensen, Kaj A ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anti OKT3 antibodies; Kidney transplantation

Indexed keywords

DRUG ANTIBODY; LYMPHOCYTE ANTIBODY; OKT 3; ORTHOCLONE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0029978479     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365599609181304     Document Type: Article

References (18)

1. Birkeland SA, Svendsen V, Rohr N, Hansen BL, Elbirk A, Foged N, Køhler F. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation. Transplant Proc 1988; 20: 451-454.
2. Birkeland SA, Bach JF, Chatenoud L, Jørgensen KA, Strate M, Elbirk A, Rohr N, Svendsen V. First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti OKT3 IgM and/or IgG immunization. Transplant Proc 1990; 22: 221-222.
3. Chatenoud L, Baudrihaye MF, Chkoff N, Kreis H, Goldstein G, Bach JF. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3. J. Immunol. 1986; 137: 830-838.
4. Chatenoud L. Humoral Immune Response Against OKT3. Transplant Proc 1993; 25, (Suppl 1): 68-73.
5. Cosimi AB. The clinical usefulness of antilymphocyte antibodies. Transplantation Proceedings 1983; 25: 583-589.
6. Cosimi AB, Burton RC, Colvin RB, et al. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 1981; 32: 535-539.
7. Delaney VB, Campbell WG, Nasr SA, McCue PA, Warshaw B, Whelchel JD. Efficacy of OKT3 monoclonal antibody therapy in steroid-resistant, predominantly vascular acute rejection. Transplantation 1988; 45: 743-748.
8. First MR, Schroeder TJ, Hurtubise PE, et al. Successful retreatment of allograft rejection with OKT3. Transplantation 1989; 47: 88-91.
9. Hansen BL, Foged N, Nielsen E, Elbirk A, Rohr N, Svendsen V, Birkeland SA. Fine-Needle aspiration cytology during treatment with orthoclone monoclonal antibody OKT3 for acute cellular rejection after renal transplantation. Transplant Proc 1988; 20: 626-628.
10. Häyry P, von Willebrandt E. Practical guidelines for tine needle aspiration biopsy of human renal allografts. Ann. Clin Res 1981; 13: 288-306.
11. Jørgensen KA, Rohr N, Elbirk A, Svendsen V, Birkeland SA. Minnesota-ALG, forced diuresis, careful control of hydration, virus infection prophylaxis and dopamine infusion in human renal transplantation. Transplant Proc 1992; 24: 358.
12. Jørgensen KA, Strate M, Svendsen V, Rohr N, Elbirk A, Birkeland SA. Fine-needle aspiration biopsy during and after OKT3. Transplant Proc 1989; 21: 3594.
13. Jørgensen KA, Strate M, Svendsen V, Rohr N, Elbirk A, Birkeland SA. Are FNAB correction factors correct? Transplant Proc 1989; 21: 3603.
14. Legendre C, Kreis H, Bach JF, Chatenoud L. Prediction of successful allograft rejection retreatment with OKT3. Transplantation 1992; 53: 87-90.
15. Ortho multicenter transplant study group. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. New Engl J Med 1985; 313: 337-342.
16. Shield CF, Cosimi AB, Tolkoff-Rubin N, Rubin RH, Herrin J, Russel PS. Use of antithymocyte globulin for reversal of acute allograft rejection. Transplantation 1979; 28: 461-464.
17. Shroeder TJ, First MR, Mansour MH, et al. Antimurine antibody formation following OKT3 therapy. Transplantation 1990; 49: 48-51.
18. Simonian SJ, Lyons P, Chvala R, et al. Reversal of acute cadaveric renal allograft rejection with added ATG treatment. Transplant Proc 1983; 25: 604-607.